tradingkey.logo

Knight Therapeutics Inc: Entered In Definitive Asset Purchase Agreement With Endo & Paladin Pharma To Acquire Paladin Business

ReutersMar 11, 2025 10:48 AM

- Paladin Ltd 0495.HK:

  • KNIGHT THERAPEUTICS INC: WILL PAY AN UPFRONT PAYMENT OF $120 MILLION IN CASH, INCLUDING INVENTORY WITH A VALUE OF $20 MILLION

  • KNIGHT THERAPEUTICS INC: ENTERED IN DEFINITIVE ASSET PURCHASE AGREEMENT WITH ENDO & PALADIN PHARMA TO ACQUIRE PALADIN BUSINESS

  • KNIGHT THERAPEUTICS INC: MAY PAY FUTURE CONTINGENT PAYMENTS OF UP TO $15 MILLION UPON ACHIEVING CERTAIN SALES MILESTONES

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI